Medicure Inc. (CVE:MPH – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as C$0.67 and last traded at C$0.67, with a volume of 16000 shares. The stock had previously closed at C$0.81.
Medicure Trading Down 2.9 %
The company has a market capitalization of C$6.99 million, a P/E ratio of -3.44 and a beta of 0.90. The company has a debt-to-equity ratio of 4.65, a quick ratio of 1.29 and a current ratio of 2.03. The company’s fifty day simple moving average is C$0.83 and its 200-day simple moving average is C$0.92.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Recommended Stories
- Five stocks we like better than Medicure
- Overbought Stocks Explained: Should You Trade Them?
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Stock Market Sectors: What Are They and How Many Are There?
- DuPont’s Electronics Spinoff: The Start of Something Big
- What Do S&P 500 Stocks Tell Investors About the Market?
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
